Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Jason Loveridge Insider Profile
4 Followers
Jason Loveridge, Director at Invex Therapeutics Ltd., holds 3.37M shares in Invex Therapeutics Ltd. (Ticker: AU:IXC). Most recently, Jason Loveridge Bought AU$38,462 shares of Invex Therapeutics Ltd. on Jul 03, 2020 for an estimated value of 50.00K.
Jason Loveridge has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Roles
Director
Roles that Jason Loveridge holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Jason Loveridge
Jason Loveridge's Trading History
List of latest transactions for each holding click on a transaction to see Jason Loveridge's performance on stock
You May Also Like
Jason Loveridge insider profile FAQ
What is the percentage of profitable transactions made by Jason Loveridge?
The percentage of profitable transactions made by Jason Loveridge is ―.
What is the average return per transaction made by Jason Loveridge?
The average return per transaction made by Jason Loveridge is ―.
What stocks does Jason Loveridge hold?
Jason Loveridge holds: AU:IXC stocks.
What was Jason Loveridge’s latest transaction?
Jason Loveridge latest transaction was an Informative Buy of AU$50.00K.
What was Jason Loveridge's most profitable transaction?
Jason Loveridge’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Jason Loveridge's role in Invex Therapeutics Ltd.?
Jason Loveridge's role in Invex Therapeutics Ltd. is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.